Taken together, the application of traditional tumor markers in chemotherapy monitoring is relatively limited whereas the changes of the RAI14 levels reflect not only drug efficacy and organ damage but furthermore also bone marrow suppression, etc. These data are much more informative for clinical patient evaluation with regard to an adjustment of drug dosage and formulation of the medication plan. This evidence concerns the gene RAI14 and neoplasm.